Results 71 to 80 of about 33,626 (230)
Dementia and Geriatric Cognitive Disorders Extra, 2011 Background/Aims: Behavioural and psychological symptoms of dementia (BPSD) in Alzheimer’s disease (AD) greatly increase caregiver burden. The abilities of donepezil and memantine to manage BPSD within their licensed indications in AD were compared ...
I.A. Lockhart, M.E. Orme, S.A. Mitchell
doaj +1 more source
Does treatment with donepezil improve memory for patients with mild cognitive impairment? [PDF]
, 2006 Donepezil (Aricept) has potential benefit in delaying risk of progression to Alzheimer's disease in the first year of treatment, but this benefit is not seen at 3 years.
Martin, Sandra I., Stiles, Melissa M.
core
ASS234, as a new Multi-Target Directed propargylamine for Alzheimer’s disease therapy [PDF]
, 2016 MU and JMC thank MINECO (Spain) for support (Grant SAF2012-33304; SAF2015-65586-R). RRR, MU, GE and JMC thank EU (COST Action 1103) for support.The complex nature of Alzheimer’s disease (AD) has prompted the design of Multi-Target-Directed Ligands (MTDL)
Bolea, Irene +8 more
core +4 more sources
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.
Dimosthenis Tsapekos +30 more
wiley +1 more source
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease [PDF]
, 2017 Available cholinergic drugs for treating Alzheimer's disease (AD) provide modest symptomatic benefit. We hypothesized that co-administration of a peripheral anticholinergic to reduce dose-limiting adverse effects (AEs) would enable the safe/tolerable use
Chase, Thomas N. +2 more
core +2 more sources
Acta Ophthalmologica, EarlyView.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis [PDF]
, 2003 Background Cholinesterase inhibitors, such as galantamine, donepezil and rivastigmine are approved for symptomatic treatment of Alzheimer's Disease (AD) in Canada. In making choices amongst these drugs, one should consider their clinical merits and their
Jaime Caro +5 more
core +2 more sources
Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population‐Based Comparison
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims Diabetes is increasingly recognised as a major contributor to cognitive decline and dementia, but the risk varies by diabetes type and treatment intensity. We compared the risk of all‐cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) among individuals with and without diabetes.
Ji Eun Jun +3 more
wiley +1 more source
Neural Regeneration Research, 2016 Acupuncture can be used to treat various nervous system diseases. Here, 168 vascular dementia patients were orally administered donepezil hydrochloride alone (5 mg/day, once a day for 56 days), or combined with acupuncture at Shenting (DU24), Tianzhu ...
Qiang Liu +5 more
doaj +1 more source
Journal of the American Geriatrics Society, EarlyView.Overview of study.
Jasmine Mah +17 more
wiley +1 more source